Ameriprise Financial Inc Cbd Md, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.0 - $21.78 $0 - $421,595	-19,357 Reduced 3.38%	553,812 $125,000
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-15,140 Reduced 2.57%	573,169 $252,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	245,547 Added 71.64%	588,309 $612,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $6.95 $0 - $258,109	37,138 Added 12.15%	342,762 $370,000
Q3 2021 Nov 15, 2021	BUY	$0.0 - $7.49 $0 - $807,354	107,791 Added 54.49%	305,624 $636,000
Q2 2021 Aug 16, 2021	BUY	$7.46 - $9.49 $264,636 - $336,648	35,474 Added 21.85%	197,833 $574,000
Q1 2021 May 17, 2021	BUY	$7.81 - $10.5 $364,711 - $490,329	46,698 Added 40.37%	162,359 $672,000
Q4 2020 Feb 12, 2021	BUY	$7.36 - $9.0 $851,264 - $1.04 Million	115,661 New	115,661 $341,000

125K

Ticker YCBD
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,555,600
Market Cap $29.1M
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.